By Roland Sebestyén
The UK CBD market’s newest stars have announced new partnership with investors and famous athletes.
Fourfive, the CBD and nutrition brand established by international rugby stars George Kruis and Dom Day, today announced that it has secured a pre-raise investment from a number of high profile sports and business professionals.
Dom Day and George Kruis, co-founders of Fourfive, said: “Our journey so far has been nothing short of amazing.
“Both the CBD and nutrition lines we have developed are premium quality and our customers love them. Our growth has been spectacular and we’ve already had three offers to buy the company at very tempting valuations.
“We think we can create even more value for our private investors before we go for a Series A round.”
The cash from the raise will be used to further expand its sales programme into retail and double down on above and below the line marketing activity.
Over the last few years, Fourfive has since expanded its offering to include a range of premium vitamin supplements.
In a relatively short period of time, large multiples have backed the Fourfive brand with Boots, Freemans and Amazon, among a growing number of outlets who are supporting and promoting the products.
Fourfive also runs an active programme of supporting athletes as they prepare for life after sport through a network of mentors and advisors, called ‘Teamplayers’ which already includes more than 20 athletes.
Among the athletes are Dylan Hartley (ex-England rugby international and captain), Jack Nowell (England Rugby international), Maddie Hinch (England Hockey player), Naomi Broady (former top 100 tennis player) and Rylee Foster from Liverpool Women’s.
Jason Roy, an International England Cricket Player, said: “What really attracted me to investing in Fourfive was not only the passion Fourfive has around striving for the best products but also the efforts that are going into ‘off-field’ areas such as supporting athletes transition and grass roots sports charities.
“I am excited to be part of the journey along with so many other interesting investors.”
According to the Association for the Cannabinoid Industry (ACI) and Centre for Medicinal Cannabis (CMC) the UK CBD sector is expected to be worth £690 million in annual sales for 2021.